Entero Therapeutics Inc. (ENTO)
NASDAQ: ENTO
· Real-Time Price · USD
3.15
0.85 (36.96%)
At close: Sep 12, 2025, 3:59 PM
3.10
-1.59%
After-hours: Sep 12, 2025, 06:51 PM EDT
Entero Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 35.6K | 47.89K | 55.21K | 78.62K | 66.15K | 76.7K | 91.96K | 90.83K | 98.53K | 106.19K | 215.97K | 331.68K | 300.85K | 270.35K | 138K | n/a | n/a |
Gross Profit | n/a | -35.6K | -47.89K | -55.21K | -78.62K | -66.15K | -76.7K | -91.96K | -90.83K | -98.53K | -106.19K | -215.97K | -331.68K | -300.85K | -270.35K | -138K | n/a | n/a |
Operating Income | -4.56M | -7.34M | -15.75M | -18.64M | -20.18M | -20.93M | -15.77M | -11.68M | -8.24M | -4.07M | -12.68K | -19.21K | -54K | -57.87K | -56.7K | -65.29K | -38.6K | -31.72K |
Interest Income | n/a | 218.00 | 446.00 | 670.00 | 899.00 | 886.00 | 2.53K | 6.99K | 9.43K | 10.15K | 8.41K | 4.9K | 2.24K | 1.32K | 1.58K | 890.70 | 2.09K | 4.39K |
Pretax Income | -4.71M | -7.47M | -15.81M | -18.72M | -20.26M | -21.02M | -15.79M | -11.7M | -8.26M | -4.08M | -14.63K | -21.82K | -56.61K | -60.48K | -58.54K | -64.77K | -39.68K | -35.1K |
Net Income | -17.08M | -24.89M | -18.06M | -9.92M | -10.78M | -6.16M | -15.79M | -15.68M | -7.85M | -9.07M | -14.63M | -21.82M | -56.61M | -60.48M | -58.54M | -64.77M | -39.68M | -35.1M |
Selling & General & Admin | 4.3M | 6.84M | 14.7M | 16.3M | 17.04M | 16.7M | 10.74M | 7.95M | 5.53M | 2.71M | 11.99K | 12.85K | 15.96K | 17.09K | 18.38K | 18.05K | 13.94K | 11.62K |
Research & Development | 254.88K | 463.84K | 1.01M | 2.3M | 3.1M | 4.24M | 5.03M | 3.73M | 2.72M | 1.37M | 15.28K | 20.96K | 38.04K | 40.78K | 38.32K | 47.24K | 24.66K | 20.1K |
Other Expenses | n/a | n/a | -653 | -1.15K | -1.15K | -3.76K | -4.22K | 2.83K | 2.83K | 5.45K | 6.56K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 4.56M | 7.31M | 15.71M | 18.6M | 20.14M | 20.93M | 15.77M | 11.68M | 8.25M | 4.08M | 23.4K | 30.59K | 56.6K | 60.47K | 58.53K | 64.75K | 38.47K | 31.58K |
Interest Expense | 53.97K | 17.9K | 66.2K | 73.25K | 74.5K | 79.68K | 22.46K | 21.61K | 21.22K | 19.26K | 15.88K | 12.08K | 11.96K | 11.7K | 11.23K | 11.04K | 1.21M | 3.51M |
Selling & Marketing Expenses | n/a | -35.6K | -35.6K | -35.6K | -35.6K | n/a | n/a | -115 | -79 | -29 | -1 | -72 | -29 | -22 | 2.00 | 59.00 | 35.00 | -22 |
Cost & Expenses | 4.56M | 7.34M | 15.75M | 18.64M | 20.18M | 20.93M | 15.77M | 11.68M | 8.25M | 4.08M | 23.4K | 30.59K | 56.6K | 60.47K | 58.53K | 64.75K | 38.47K | 31.58K |
Income Tax Expense | 10.6M | 14.86M | n/a | -10.6M | -10.6M | -14.86M | n/a | -1.7M | -1.7M | -1.7M | -1.7M | 1.1K | 1.06K | 4.37K | 25.98K | 26.77K | 34.81K | 31.36K |
Shares Outstanding (Basic) | 4.77M | 4.77M | 4.75M | 4.55M | 2.29M | 1.76M | 357.32K | 378.3K | 113.55K | 114.03K | 49.75K | 11.44K | 5.19K | 3.7K | 3.54K | 2.22K | 1.86K | 1.32K |
Shares Outstanding (Diluted) | 4.77M | 4.77M | 4.75M | 4.55M | 2.29M | 1.32M | 357.32K | 378.3K | 113.55K | 114.03K | 49.75K | 11.61K | 5.19K | 3.7K | 3.54K | 2.22K | 1.86K | 1.32K |
EPS (Basic) | -3.63 | -7.26 | -3.86 | -12.77 | -21.28 | -54.33 | -93.15 | -161.79 | 217.41 | -787.29 | -3.35K | -6.43K | -20.47K | -24.42K | -27.65K | -49.47K | -43.63K | -45.68K |
EPS (Diluted) | -3.63 | -7.26 | -2.75 | -11.66 | -20.17 | -53.22 | -93.15 | -161.79 | 211.88 | -792.82 | -3.36K | -6.44K | -20.47K | -24.42K | -27.65K | -49.47K | -43.63K | -45.68K |
EBITDA | -4.66M | -7.42M | -15.7M | -18.58M | -20.12M | -20.9M | -15.74M | -15.61M | -7.77M | -9M | -14.53M | -21.61M | -56.29M | -60.03M | -57.99M | -64.21M | -37.91M | -31.02M |
EBIT | -4.67M | -7.45M | -15.75M | -18.64M | -20.18M | -20.94M | -15.77M | -15.66M | -7.83M | -9.05M | -14.61M | -21.8M | -56.6M | -60.47M | -58.53M | -64.75M | -38.47M | -31.58M |
Depreciation & Amortization | 1.34K | 36.65K | 48.95K | 56.27K | 62.25K | 34.25K | 29.27K | 21.96K | 14.65K | 7.34K | 29.27 | 159.16 | 290.10 | 416.66 | 542.25 | 548.18 | 549.99 | 557.44 |